Clostridium difficile Infection Epidemiology

View All

Recurrent Clostridium Difficile Infection (rCDI) Market Outlook, Emerging Therapies, and Epidemiology
Evaluating the Potential of Emerging Therapies for Recurrent Clostridium Difficile Infection (rCDI)

Clostridium difficile Infection (CDI), one of the most common nosocomial and community-acquired infections globally, is a major public health challenge. The Clostridium difficile bacteria are a toxin-producing pathogen that produces two types of toxins: toxin A (an enterotoxin) and toxin B (a cytotoxin). This toxin...

Find More